BeStock  
Stocks › AMLX

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2376
$27.78 −$0.01 (-0.04%)
Market closed · Oct 6, 12:40 am ET · Last extended-hours $28.56 +2.81%
Open$27.92
Prev close$27.79
Day range$27.34 – $28.09
Volume941.1K
Market cap$3.49B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-19.7x
CheapRich

Near the bottom of its 5-year range · 4th percentile, 5-year average 24.9x

Price / book14.6x
CheapRich

Near the top of its 5-year range · 91st percentile, 5-year average 4.3x

#5001 of 5315 stocks by PB (1 = cheapest)

P/E over five years

-164x119x401x683xJan '22May '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$17.31
Price vs. fair value+60.5%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 14.58 – 4.29 91% (pricier than usual) #5001 of 5315 (1 = cheapest)
PE -19.70 -20.08 24.93 4% (cheaper than usual) –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$17.31
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on AMLX.

Leave a comment

Scroll to Top